Diabetic dyslipidemia is a very common metabolic disorder, particularly in patients with type 2 diabetes. Characterized by hypertriglyceridemia and a decrease in HDL cholesterol, it is the cause of many cardiovascular comorbidities. It is therefore essential to detect this pathology as early as possible to provide rapid and appropriate management. However, given the increasing number of therapeutic possibilities for treating this disorder, it can be difficult to clinically guide one's choice. In this article, we will discuss the pathophysiology of diabetic dyslipidemia and the resulting management are presented.